Exact Sciences Corporation
EXAS
$45.66
-$1.81-3.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 811.09M | 706.79M | 713.42M | 708.66M | 699.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 811.09M | 706.79M | 713.42M | 708.66M | 699.26M |
| Cost of Revenue | 248.63M | 206.24M | 284.13M | 196.07M | 210.95M |
| Gross Profit | 562.45M | 500.55M | 429.29M | 512.59M | 488.32M |
| SG&A Expenses | 450.79M | 476.71M | 442.51M | 406.54M | 402.32M |
| Depreciation & Amortization | -- | -- | -71.06M | 24.44M | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 808.32M | 788.26M | 755.20M | 727.15M | 734.41M |
| Operating Income | 2.76M | -81.47M | -41.77M | -18.50M | -35.14M |
| Income Before Tax | -57.00K | -100.99M | -875.97M | -37.43M | -14.35M |
| Income Tax Expenses | 1.13M | 224.00K | -11.38M | 808.00K | 1.46M |
| Earnings from Continuing Operations | -1.19M | -101.22M | -864.59M | -38.24M | -15.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.19M | -101.22M | -864.59M | -38.24M | -15.81M |
| EBIT | 2.76M | -81.47M | -41.77M | -18.50M | -35.14M |
| EBITDA | 58.05M | -27.41M | 11.37M | 36.28M | 17.85M |
| EPS Basic | -0.01 | -0.54 | -4.67 | -0.21 | -0.09 |
| Normalized Basic EPS | 0.02 | -0.29 | -0.14 | -0.06 | -0.11 |
| EPS Diluted | -0.01 | -0.54 | -4.67 | -0.21 | -0.09 |
| Normalized Diluted EPS | 0.02 | -0.29 | -0.14 | -0.06 | -0.11 |
| Average Basic Shares Outstanding | 188.90M | 186.81M | 185.31M | 184.80M | 184.31M |
| Average Diluted Shares Outstanding | 188.90M | 186.81M | 185.31M | 184.80M | 184.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |